As of 2025-04-26, the Relative Valuation of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is (135.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.84 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd based on Relative Valuation is -781.4%.
The range of the Relative Valuation is (133.03) - (181.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.0x - 24.8x | 16.8x |
| Forward P/E multiples | 15.0x - 21.8x | 15.8x |
| Fair Price | (133.03) - (181.13) | (135.18) |
| Upside | -770.5% - -1012.9% | -781.4% |
| Date | P/E |
| 2025-04-23 | -2.64 |
| 2025-04-22 | -2.55 |
| 2025-04-21 | -2.48 |
| 2025-04-17 | -2.46 |
| 2025-04-16 | -2.25 |
| 2025-04-15 | -2.24 |
| 2025-04-14 | -2.23 |
| 2025-04-11 | -2.12 |
| 2025-04-10 | -2.07 |
| 2025-04-09 | -2.25 |
| 2025-04-08 | -1.99 |
| 2025-04-07 | -2.16 |
| 2025-04-04 | -2.24 |
| 2025-04-03 | -2.48 |
| 2025-04-02 | -2.86 |
| 2025-04-01 | -2.73 |
| 2025-03-31 | -2.90 |
| 2025-03-28 | -3.33 |
| 2025-03-27 | -3.42 |
| 2025-03-26 | -3.48 |
| 2025-03-25 | -3.60 |
| 2025-03-24 | -3.74 |
| 2025-03-21 | -3.44 |
| 2025-03-20 | -3.40 |
| 2025-03-19 | -3.47 |
| 2025-03-18 | -3.48 |
| 2025-03-17 | -3.58 |
| 2025-03-14 | -3.51 |
| 2025-03-13 | -3.40 |
| 2025-03-12 | -3.55 |
| 2025-03-11 | -3.55 |
| 2025-03-10 | -3.33 |
| 2025-03-07 | -3.60 |
| 2025-03-06 | -3.67 |
| 2025-03-05 | -3.73 |
| 2025-03-04 | -3.78 |
| 2025-03-03 | -3.87 |
| 2025-02-28 | -4.48 |
| 2025-02-27 | -4.41 |
| 2025-02-26 | -4.48 |
| 2025-02-25 | -4.39 |
| 2025-02-24 | -4.28 |
| 2025-02-21 | -4.45 |
| 2025-02-20 | -4.80 |
| 2025-02-19 | -4.73 |
| 2025-02-18 | -4.75 |
| 2025-02-14 | -5.00 |
| 2025-02-13 | -5.04 |
| 2025-02-12 | -5.08 |
| 2025-02-11 | -5.13 |